Investigating the Impact of JASPER Behavioral Therapy in Children With Down Syndrome
Sponsor: Boston Children's Hospital
Listed as NCT05638412, this NA trial focuses on Down Syndrome and remains ongoing. Sponsored by Boston Children's Hospital, it has been updated 9 times since 2023, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
9 versions recorded-
May 2025 — Present [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Sep 2024 — May 2025 [monthly]
Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Recruiting NA
-
Jun 2024 — Jul 2024 [monthly]
Recruiting NA
-
Dec 2023 — Jun 2024 [monthly]
Recruiting NA
▶ Show 4 earlier versions
-
Sep 2023 — Dec 2023 [monthly]
Recruiting NA
-
Apr 2023 — Sep 2023 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Feb 2023 — Apr 2023 [monthly]
Not Yet Recruiting NA
-
Jan 2023 — Feb 2023 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Boston Children's Hospital
For direct contact, visit the study record on ClinicalTrials.gov .